Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein
- DOI
- 10.3390/molecules27238513
- Published
- 2022-12-03
- Container
- Molecules
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/molecules27238513,
title = {Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein},
author = {Elisabetta Marini and Marco Marino and Giulia Gionfriddo and Federica Maione and Marta Pandini and Daniele Oddo and Marta Giorgis and Barbara Rolando and Federica Blua and Simone Gastaldi and Serena Marchiò and Sandra Kovachka and Francesca Spyrakis and Eleonora Gianquinto and Federica Di Nicolantonio and Massimo Bertinaria},
year = {2022},
journal = {Molecules},
doi = {10.3390/molecules27238513},
url = {https://doi.org/10.3390/molecules27238513}
}RIS
TY - JOUR TI - Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein AU - Elisabetta Marini AU - Marco Marino AU - Giulia Gionfriddo AU - Federica Maione AU - Marta Pandini AU - Daniele Oddo AU - Marta Giorgis AU - Barbara Rolando AU - Federica Blua AU - Simone Gastaldi AU - Serena Marchiò AU - Sandra Kovachka AU - Francesca Spyrakis AU - Eleonora Gianquinto AU - Federica Di Nicolantonio AU - Massimo Bertinaria PY - 2022 JO - Molecules DO - 10.3390/molecules27238513 UR - https://doi.org/10.3390/molecules27238513 ER -
APA
Marini, E., Marino, M., Gionfriddo, G., Maione, F., Pandini, M., Oddo, D., Giorgis, M., Rolando, B., Blua, F., Gastaldi, S., Marchiò, S., Kovachka, S., Spyrakis, F., Gianquinto, E., Nicolantonio, F. D., & Bertinaria, M. (2022). Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. Molecules. https://doi.org/10.3390/molecules27238513
Source records
- crossref · retrieved 2026-09-27T14:27:24.935Z